SARS-CoV-2 antibodies after booster vaccination. Identification of subgroups with poor response
Description
CONCLUSION: Patients treated with antiCD20 drugs, hematologic patients and transplanted patients (mainly lung and kidney) have a higher risk of not achieving post-vaccination immunity. It is essential to identify them in order to individualize and
